Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide meta-analysis of 92 cardiometabolic protein serum levels. | Mol Metab | 2023 | 37778719 | PubTator, text mining | PubMed |
| mAb therapy controls CNS-resident lyssavirus infection via a CD4 T cell-dependent mechanism. | EMBO Mol Med | 2023 | 37767784 | PubTator, text mining | PubMed |
| Comparative Proteomic Analysis of Exosomes Derived from Patients Infected with Non-Tuberculous Mycobacterium and Mycobacterium tuberculosis. | Microorganisms | 2023 | 37764178 | PubTator, text mining | PubMed |
| Genetic Variants Identified by Whole Exome Sequencing in a Large Italian Family with High Plasma Levels of Factor VIII and Von Willebrand Factor. | Int J Mol Sci | 2023 | 37762470 | PubTator, text mining | PubMed |
| Histidine-rich glycoprotein: antithrombosis without bleeding. | Blood Adv | 2023 | 37756538 | PubTator, text mining | PubMed |
| "I Just Want You to Hear That Term": Characterizing Language Used in Fetal Cardiology Consultations. | J Cardiovasc Dev Dis | 2023 | 37754823 | PubTator, text mining | PubMed |
| Adaptive Guided Equilibrium Optimizer with Spiral Search Mechanism to Solve Global Optimization Problems. | Biomimetics (Basel) | 2023 | 37754134 | PubTator, text mining | PubMed |
| Combined FOLFOX4 with all-trans retinoic acid versus FOLFOX4 with placebo in treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a randomized, double-blind comparative study. | Signal Transduct Target Ther | 2023 | 37752117 | PubTator, text mining | PubMed |
| A combination of strongly associated prothrombotic single nucleotide polymorphisms could efficiently predict venous thrombosis risk. | Front Cardiovasc Med | 2023 | 37745125 | PubTator, text mining | PubMed |
| Comprehensive proteomics and meta-analysis of COVID-19 host response. | Nat Commun | 2023 | 37739942 | PubTator, text mining | PubMed |
| [Analysis of a Chinese pedigree affected with Hereditary FⅫ deficiency due to compound heterozygous variants of F12 gene]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2023 | 37730224 | PubTator, text mining | PubMed |
| Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond. | Front Physiol | 2023 | 37711466 | PubTator, text mining | PubMed |
| "Familial Multiple Coagulation Factor Deficiencies of FXI and FXII in an Asymptomatic Saudi Woman". | J Investig Med High Impact Case Rep | 2023 | 37705386 | PubTator, text mining | PubMed |
| Clinical Values of Coagulation Factors X, XI, and XII in Cerebral Venous Sinus Thrombosis During Perinatal State. | Clin Appl Thromb Hemost | 2023 | 37697669 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy. | Front Immunol | 2023 | 37680629 | PubTator, text mining | PubMed |
| Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders. | J Med Chem | 2023 | 37669040 | PubTator, text mining | PubMed |
| Decreased plasma cartilage acidic protein 1 in COVID-19. | Physiol Rep | 2023 | 37667413 | PubTator, text mining | PubMed |
| Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. | World J Gastroenterol | 2023 | 37664153 | PubTator, text mining | PubMed |
| Cooperation between neurovascular dysfunction and Aβ in Alzheimer's disease. | Front Mol Neurosci | 2023 | 37654789 | PubTator, text mining | PubMed |
| New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI Inhibitors. | Arterioscler Thromb Vasc Biol | 2023 | 37650326 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=18